Although, as Cooper points out, all weight loss has the potential for muscle loss, so this effect isnt unique to Ozempic
Hirata, Y
Because obesity is recognized as a chronic disease involving persistent metabolic, hormonal, and neurological changes, most patients require long-term or indefinite treatment to maintain weight loss and health improvements
When possible, choose antipsychotics with a favorable weight/metabolic profile, such as aripiprazole, brexpiprazole, lumateperone, lurasidone, or ziprasidone
Wegovy is a glucagon-like peptide-1 (GLP-1) receptor agonist licensed for chronic weight management in adults with obesity (BMI 30 kg/m) or overweight (BMI 27 kg/m) with at least one weight-related comorbidity